Search This Blog

Tuesday, February 26, 2019

Jazz Pharmaceuticals sees FY19 adj. EPS $14.30-$15.00, consensus $13.98

Sees FY19 revenue $-$2.13B, consensus $2.03B.
https://thefly.com/landingPageNews.php?id=2870635
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)